4.6 Article

Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats

Journal

TOXICOLOGY AND APPLIED PHARMACOLOGY
Volume 247, Issue 2, Pages 83-90

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2010.06.011

Keywords

Breast cancer; Quercetin; Phytoestrogen; Estrogen; ACI rat

Funding

  1. National Institutes of Health [ES009089, CA 109551]

Ask authors/readers for more resources

Phytoestrogens are plant compounds that structurally mimic the endogenous estrogen 17 beta-estradiol (E-2). Despite intense investigation, the net effect of phytoestrogen exposure on the breast remains unclear. The objective of the current study was to examine the effects of quercetin on E-2-induced breast cancer in vivo. Female ACI rats were given quercetin (2.5 g/kg food) for 8 months. Animals were monitored weekly for palpable tumors, and at the end of the experiment, rats were euthanized, breast tumor and different tissues excised so that they could be examined for histopathologic changes, estrogen metabolic activity and oxidant stress. Quercetin alone did not induce mammary tumors in female ACI rats. However, in rats implanted with E-2 pellets, co-exposure to quercetin did not protect rats from E-2-induced breast tumor development with 100% of the animals developing breast tumors within 8 months of treatment. No changes in serum quercetin levels were observed in quercetin and quercetin + E-2-treated groups at the end of the experiment. Tumor latency was significantly decreased among rats from the quercetin + E-2 group relative to those in the E-2 group. Catechol-O-methyltransferase (COMT) activity was significantly downregulated in quercetin-exposed mammary tissue. Analysis of 8-isoprostane F-2 alpha, (8-iso-PGF(2 alpha)) levels as a marker of oxidant stress showed that quercetin did not decrease E-2-induced oxidant stress. These results indicate that quercetin (2.5 g/kg food) does not confer protection against breast cancer, does not inhibit E-2-induced oxidant stress and may exacerbate breast carcinogenesis in E-2-treated ACI rats. Inhibition of COMT activity by quercetin may expose breast cells chronically to E-2 and catechol estrogens. This would permit longer exposure times to the carcinogenic metabolites of E-2 and chronic exposure to oxidant stress as a result of metabolic redox cycling to estrogen metabolites, and thus quercetin may exacerbate E-2-induced breast tumors in female ACI rats. (C) 2010 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available